Scarlet fever

AB1_SCARLET_FEVER

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A38 Hospital discharge: ICD-9 — 03[4] Hospital discharge: ICD-8 — 03[4] Hospital discharge: excluded ICD-9 — 034[0] Hospital discharge: excluded ICD-8 — 034[0] Cause of death: ICD-10 — A38 Cause of death: ICD-9 — 03[4] Cause of death: ICD-8 — 03[4] Cause of death: excluded ICD-9 — 034[0] Cause of death: excluded ICD-8 — 034[0] 2 out of 7 registries used, show all original rules.	285
4. Check minimum number of events None	285
5. Include endpoints None	285
6. Filter based on genotype QC (FinnGen only)	264

Control definitions (FinnGen only)

Control exclude: AB1_OTHER_BACTERIAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_SCARLET_FEVER
CONTROL_EXCLUDE	AB1_OTHER_BACTERIAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A38
HD_ICD_9	03[4]
HD_ICD_8	03[4]
HD_ICD_10_EXCL
HD_ICD_9_EXCL	034[0]
HD_ICD_8_EXCL	034[0]
COD_MAINONLY
COD_ICD_10	A38
COD_ICD_9	03[4]
COD_ICD_8	03[4]
COD_ICD_10_EXCL
COD_ICD_9_EXCL	034[0]
COD_ICD_8_EXCL	034[0]
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Scarlet fever based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4075	1777	2286
Only index persons	3185	1380	1805
Unadjusted period prevalence (%)
Whole population	0.06	0.05	0.06
Only index persons	0.06	0.05	0.07
Median age at first event (years)
Whole population	7.01	6.65	7.16
Only index persons	7.59	7.19	7.90

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	264	147	117
Unadjusted period prevalence (%)	0.05	0.05	0.05
Median age at first event (years)	10.84	9.11	13.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
269: Matched controls
2690

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

03419

ICD-8 Finland

Streptococcal sore throat and scarlet fever, Scarlatina NUD

+∞

98.1

A38

ICD-10 Finland

Scarlet fever

+∞

95.7

03417

ICD-8 Finland

Streptococcal sore throat and scarlet fever, Scarlatina suspecta

+∞

46.2

0341A

ICD-9 Finland

Streptococcal sore throat and scarlatina, Scarlatina[SCARLATINA STREPTOCOCCUS BETAHAEMOLYTICUS,RYHMÄ-A]

+∞

16.8

0341X

ICD-9 Finland

Streptococcal sore throat and scarlatina, Scarlatina[SCARLATINA STREPTOCOCCUS BETAHAEMOLYTICUS,MUU]

+∞

15.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

25.4

14.0

A46

ICD-10 Finland

Erysipelas

4.2

8.8

03410

ICD-8 Finland

Streptococcal sore throat and scarlet fever, Scarlatina cum complicatione

+∞

8.4

A41.9

ICD-10 Finland

Sepsis, unspecified

+∞

7.3

H02AB09

ATC

hydrocortisone; systemic

8.0

6.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

4.94

8.98

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

143

3.02

8.29

2.7

2.4

—

(3023368) Bacteria identified in Blood by Culture

365

2.24

7.20

4.2

3.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.41

5.16

1.6

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

227

2.18

4.92

1.7

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

5.41

4.83

1.9

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

5.41

4.83

1.8

2.0

—

(42870588) Differential panel, method unspecified - Blood

104

706

1.77

4.73

10.1

6.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

194

1577

1.83

4.65

9.7

6.6

80.16

78.12

u/l

0.25

185

1505

(40761536) Microorganisms panel - Urine sediment

163

2.32

4.62

4.8

2.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

3.47

4.39

1.9

—

(3042936) Bacteria identified in Isolate by Culture

230

2.09

4.39

1.8

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.55

4.24

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.55

4.24

1.6

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

5.41

4.19

1.9

2.1

—

(3032080) INR in Blood by Coagulation assay

103

720

1.70

4.11

10.2

7.3

1.10

1.11

inr

0.10

584

(3035715) Granulocytes [#/volume] in Blood

3.93

3.95

1.9

3.5

3.79

3.69

e9/l

0.07

(3024561) Albumin [Mass/volume] in Serum or Plasma

105

749

1.66

3.82

9.1

4.4

37.52

37.99

g/l

0.47

724

(3021589) Normoblasts [#/volume] in Blood

134

1025

1.61

3.64

15.8

8.8

0.00

e9/l

0.65

117

832

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

130

993

1.60

3.52

8.4

5.2

10.21

11.47

umol/l

0.75

122

955

(3022145) Colonoscopy Study observation

229

1.93

3.40

1.5

1.4

—

(3010421) pH of Blood

3.13

3.30

6.2

1.8

7.40

7.42

0.37

(3004588) Protein electrophoresis panel - Serum or Plasma

2.68

3.28

1.0

2.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

4.86

3.26

1.8

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

3.65

3.02

1.5

—

(3035933) Granulocytes/Leukocytes in Blood

2.73

3.02

1.9

2.8

55.40

55.87

0.06

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

166

1.98

2.91

5.1

2.6

0.23

g/l

0.14

161

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

522

1.61

2.90

1.8

1.7

—

(4035726) Immunohistochemistry procedure

111

2.17

2.82

1.2

1.3

—

(3042733) HLA Ab [Presence] in Serum

8.46

2.76

4.6

1.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

8.46

2.76

2.0

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

8.46

2.76

2.0

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

8.46

2.76

2.0

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

590

1.56

2.74

5.1

3.0

0.00

estimate

0.50

212

(3037522) Nuclear Ab [Titer] in Serum

335

1.68

2.71

1.6

1.4

146.67

571.73

titre

4.90

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

4.31

2.70

1.1

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

304

1.70

2.66

1.8

1.6

420.25

65018093.42

pmol/l

0.76

283

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

640

1.53

2.61

3.1

2.9

13.67

25.90

ng/l

1.50

322

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

108

2.13

2.60

1.8

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

188

1.86

2.60

2.1

1.6

1452.38

1106.06

nmol/l

1.43

150

(3017732) Neutrophils [#/volume] in Blood

266

1.73

2.59

1.9

3.3

4.07

7.70

e9/l

0.94

248

(3026782) Osmolality of Urine

345

1.63

2.42

3.9

2.2

473.92

534.39

mosm/kgh2o

0.90

293

(46235355) HIV 1 and 2 tests - Meaningful Use set

650

1.50

2.41

1.9

2.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

3.71

2.38

6.0

3.2

12.46

7.00

u/ml

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.20

2.34

1.6

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

450

1.55

2.33

3.4

2.0

2.87

2.59

mg/l

0.56

391

(44790047) Parainfluenza type 1 nucleic acid detection

3.55

2.29

2.1

2.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

3.55

2.29

2.1

2.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

3.55

2.29

2.1

2.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

3.55

2.29

2.1

2.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

141

1169

1.43

2.23

6.4

4.2

6.61

6.29

mmol/l

0.68

130

1092

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2.48

2.23

3.2

4.7

23.94

23.49

mmol/l

0.18

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

237

1.70

2.23

2.0

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

102

802

1.44

2.14

15.7

5.8

1.21

1.22

mmol/l

1.07

756

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

186

1630

1.46

2.13

5.8

3.8

8.94

8.10

mm/h

0.49

175

1554

(3014148) Varicella zoster virus Ab [Titer] in Serum

2.62

2.10

1.2

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

140

1.87

2.09

21.3

5.7

0.19

1.11

mmol/l

0.64

(3013290) Carbon dioxide [Partial pressure] in Blood

2.97

2.09

8.1

1.3

4.69

4.90

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

2.97

2.09

8.1

1.3

8.88

9.58

kpa

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

5.07

2.08

1.8

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

5.07

2.08

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

3.14

2.03

1.8

1.3

—

(1616796) Gas panel - Central venous blood

2.87

2.02

8.9

2.0

—

(3022096) Basophils/Leukocytes in Blood

128

1058

1.40

1.99

10.0

6.5

0.71

0.70

0.08

123

1009

(3015377) Calcium [Moles/volume] in Serum or Plasma

617

1.45

1.99

4.5

2.7

2.35

2.36

mmol/l

0.34

571

(3000991) Gas panel - Venous blood

158

1.79

1.98

25.0

8.1

—

(3026008) Bacteria identified in Urine by Culture

469

1.48

1.91

2.8

2.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

2.70

1.88

1.2

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

140

1184

1.38

1.86

9.6

6.2

2.02

2.07

e9/l

0.23

127

1056

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

177

1.72

1.85

1.9

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

2.18

1.85

2.1

1.3

144.60

130.59

au/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2.18

1.85

2.1

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.81

1.80

2.6

1.7

78.29

21.99

ng/l

—

(3002179) Metamyelocytes/Leukocytes in Blood

155

1.75

1.80

4.5

4.9

0.25

0.46

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

171

1.71

1.79

2.0

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

116

957

1.37

1.77

3.2

2.4

—

estimate

—

(44813793) Dust mix specific IgE antibody measurement

3.38

1.75

1.0

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

496

1.44

1.73

2.8

2.3

358.80

325.36

umol/l

1.49

466

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

452

1.45

1.72

2.1

1.9

0.92

1.03

mg/l

0.13

336

(3023520) Reticulocytes [#/volume] in Blood

112

1.85

1.70

3.9

2.7

64.73

69.68

e9/l

0.16

(3025159) Blasts/Leukocytes in Blood

158

1.71

1.70

4.7

5.6

0.00

0.21

—

(3006315) Basophils [#/volume] in Blood

136

1157

1.35

1.69

9.7

6.2

0.04

e9/l

0.22

123

1006

(3001604) Monocytes [#/volume] in Blood

136

1157

1.35

1.69

9.6

6.2

0.56

0.55

e9/l

0.13

123

1008

(3044640) Blood type and Crossmatch panel - Blood

616

1.40

1.68

2.8

1.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

2.09

1.68

2.2

1.4

243.13

201.47

u/ml

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2.09

1.68

2.1

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

120

1.81

1.68

22.4

6.1

24.28

24.05

mmol/l

0.18

120

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

251

2380

1.82

1.67

14.3

9.4

29.13

28.68

u/l

0.15

242

2345

(3021440) Promyelocytes/Leukocytes in Blood

159

1.70

1.66

4.4

4.9

0.25

0.08

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

152

1.71

1.63

3.1

2.4

14035.73

5979.58

u/l

0.26

(40768441) Liver Pathology biopsy report

3.62

1.62

1.6

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

136

1162

1.34

1.62

5.1

3.0

0.00

estimate

-0.00

224

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

2.38

1.60

1.1

—

(4195642) Thrombophilia screening test

2.38

1.60

1.1

1.2

—

(3003694) ABO and Rh group [Type] in Blood

732

1.37

1.60

1.7

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.25

1.59

1.2

1.3

4.33

2.82

u/ml

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

3.04

1.59

2.5

3.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

613

1.38

1.58

2.4

53.25

65.06

u/l

0.87

584

(3004789) Transferrin [Mass/volume] in Serum or Plasma

227

1.57

1.56

5.4

1.9

2.56

2.46

g/l

0.62

211

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.47

1.55

1.9

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.63

1.52

1.0

1.2

—

(44806420) Estimation of glomerular filtration rate

2.90

1.51

4.0

2.5

—

(3018418) pH of Serum or Plasma

526

1.39

1.51

4.9

3.3

7.40

0.06

365

(3030467) Casts [#/volume] in Urine by Automated count

508

1.40

1.51

6.2

2.6

0.13

0.28

e6/l

1.36

351

(3035350) Ketones [Presence] in Urine by Test strip

136

1172

1.32

1.49

5.1

3.0

0.00

estimate

-0.00

218

(3021879) Hepatitis B virus core Ab [Presence] in Serum

222

1.55

1.47

1.5

1.6

—

(3013115) Eosinophils [#/volume] in Blood

138

1195

1.32

1.44

9.9

6.5

0.19

e9/l

0.24

126

1061

(3042631) Mycobacterium sp identified in Specimen

3.16

1.44

1.6

2.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2.77

1.44

1.0

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

166

1.63

1.43

4.5

4.8

1.63

0.49

—

(36304419) Bacteria [Presence] in Urine

504

1.38

1.42

6.1

2.5

—

estimate

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.22

1.41

1.5

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

136

1183

1.30

1.35

5.2

3.0

0.09

0.00

estimate

0.49

206

(40768793) Breast Pathology biopsy report

2.18

1.35

1.1

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

456

1.38

1.31

2.9

2.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.53

1.31

1.0

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

2.53

1.31

1.0

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.53

1.31

1.0

1.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

220

2053

1.39

1.29

14.9

9.1

91.52

92.84

ml/min/173m2

0.43

198

1858

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.86

1.28

1.6

1.5

62.23

45.53

ug/l

0.76

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

105

891

1.29

1.23

15.4

6.1

1.21

1.22

mmol/l

0.96

780

(3048929) Epstein Barr virus Ab [Presence] in Serum

134

1.62

1.18

2.0

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

169

1.53

1.12

3.6

6.3

—

(40768443) Skin Pathology biopsy report

1.73

1.10

1.3

1.2

—

(3021901) Oxygen saturation in Capillary blood

2.22

1.09

4.1

3.2

92.66

91.61

—

(4268621) Lupus anticoagulant assay

2.15

1.06

2.1

2.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

283

1.40

1.06

2.1

1.8

—

(3022313) Gas panel - Capillary blood

114

1.62

1.05

29.9

6.0

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

114

1.62

1.05

1.6

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

2.30

1.04

1.0

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

2.30

1.04

1.0

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

2.30

1.04

1.0

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2.09

1.03

1.0

2.6

0.00

g/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

105

908

1.26

1.02

4.6

2.7

0.00

0.01

estimate

0.50

188

(3017143) Hepatitis C virus Ab [Presence] in Serum

374

1.34

1.02

1.7

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

604

1.29

1.02

6.0

2.7

11.98

43.86

e6/l

1.95

440

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.90

1.01

1.2

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

192

1781

1.27

1.00

5.2

4.3

14.70

14.44

pmol/l

0.77

176

1681

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.84

1.00

1.5

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.67

0.99

1.3

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.98

0.0

1.2

—

0.17

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.97

0.0

1.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

231

2199

1.36

0.96

20.1

10.6

3.94

mmol/l

0.03

225

2155

(3012544) pH of Venous blood

176

1.46

0.94

19.3

5.3

7.38

0.01

100

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

199

2108

0.78

0.94

19.4

13.6

335.13

334.29

g/l

0.63

199

2098

(3021788) Differential panel - Synovial fluid

2.25

0.94

1.7

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.64

0.89

2.0

1.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

142

1285

1.22

0.88

11.8

8.6

3.82

3.88

e9/l

0.11

131

1117

(3020682) Albumin/Creatinine [Ratio] in Urine

504

1.27

0.86

4.4

3.6

9.32

6.36

mg/mmol

0.24

339

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

107

943

1.22

0.85

2.1

1.8

1.50

1.45

mmol/l

0.21

863

(3015736) pH of Urine

108

953

1.22

0.85

4.6

2.7

6.06

6.18

0.50

568

(3009508) Creatinine [Moles/volume] in Urine

646

1.25

0.85

4.3

3.0

8.68

8.83

mmol/l

0.09

582

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

394

0.73

0.85

1.8

1.9

3.45

3.51

ratio

0.10

309

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.72

0.83

1.1

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

251

1.36

0.83

6.5

2.5

4.98

6.13

umol/l

0.38

220

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1.64

0.83

2.2

2.4

2.24

5.22

iu/l

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1.72

0.81

1.0

1.1

108.88

113.33

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.70

0.80

1.6

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

235

2257

1.33

0.79

17.5

10.3

20.96

19.55

mg/l

0.29

197

1762

(3025941) Bacteria identified in Stool by Culture

132

1.47

0.78

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

1.63

0.76

1.7

1.2

—

(3012516) Albumin [Mass/volume] in Urine

503

1.25

0.76

3.5

3.1

87.17

38.87

mg/l

0.41

342

(3020564) Creatinine [Moles/volume] in Serum or Plasma

246

2381

1.39

0.75

20.1

12.0

73.66

70.94

umol/l

0.89

246

2356

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

200

1889

1.23

0.75

3.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

2.10

0.75

4.6

3.2

14.00

19.46

u/ml

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

2.10

0.75

1.2

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

301

1.31

0.75

5.7

2.5

1.75

2.54

e6/l

0.28

144

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1.69

0.73

5.4

3.0

3.62

3.22

g/l

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

677

1.21

0.71

1.4

0.52

1.28

u/ml

1.93

194

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.94

0.71

1.2

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

103

919

1.20

0.71

4.2

2.6

74.55

73.54

nmol/l

0.16

866

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.58

0.70

3.7

4.2

0.74

0.60

0.52

(3026389) Candida sp identified in Specimen by Organism specific culture

1.87

0.69

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.52

0.68

1.6

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

703

1.20

0.64

4.0

2.4

0.00

estimate

-0.00

178

(3048689) Calprotectin [Mass/mass] in Stool

391

1.24

0.64

4.2

2.7

113.96

67.23

ug/g

0.56

310

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

300

0.74

0.64

1.6

1.7

3.53

3.46

mmol/l

0.14

219

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.65

0.62

1.1

2.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

185

1749

1.18

0.61

4.6

3.2

40.03

42.01

u/l

0.24

175

1704

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

131

1.40

0.61

1.3

1.4

429.00

287.90

miu/ml

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.2

—

2.43

—

(40768804) Tissue Pathology biopsy report

799

1.17

0.56

1.8

1.9

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

214

1.29

0.55

9.6

6.0

103.07

104.92

mmol/l

0.85

214

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

684

1.18

0.55

2.0

1.7

—

(3024928) Oxygen saturation in Venous blood

1.59

0.54

3.5

7.2

58.12

64.97

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

315

1.24

0.54

5.7

2.4

0.19

0.94

e6/l

3.08

158

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.55

0.53

1.5

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.54

0.53

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.44

0.53

2.8

2.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

207

1.28

0.52

1.3

199.96

176.84

u/ml

0.07

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.49

0.51

1.4

1.5

—

(3018095) Leukocytes [#/volume] in Urine

737

1.16

0.50

7.4

3.3

27.42

123.02

e6/l

0.86

480

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

431

1.20

0.50

1.4

1.3

2.18

7.21

u/ml

1.80

179

(21494755) Public health laboratory ask at order entry panel

396

0.81

0.50

1.3

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.57

0.49

1.6

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.54

0.48

1.0

2.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

586

1.17

0.47

4.8

4.1

—

(1761868) Lipid panel - Serum or Plasma

121

1124

1.14

0.46

3.3

2.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.38

0.44

1.1

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

400

1.18

0.42

1.7

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

215

2082

1.16

0.42

5.9

5.0

1.71

1.79

mu/l

0.47

204

1989

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.52

0.41

1.6

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.41

0.41

1.0

1.1

5.21

4.89

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.41

0.0

1.0

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.41

0.0

1.6

—

11.50

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.67

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.41

0.0

1.7

—

(40761511) CBC panel - Blood by Automated count

243

2378

1.23

0.40

16.0

9.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.40

0.0

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

614

1.14

0.39

1.6

1.3

2.22

2.15

g/l

0.11

396

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

770

1.13

0.39

1.7

1.8

98.02

96.29

pmol/l

0.11

411

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

144

1.27

0.36

2.5

2.3

63.25

83.00

ml/min/173m2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.47

0.36

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

416

1.16

0.36

1.7

1.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

465

0.86

0.35

2.1

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.40

0.35

1.0

—

(3019225) pH of Specimen

127

1.28

0.34

3.4

3.3

7.38

7.35

0.61

(3002256) Pathology report gross observation

248

1.19

0.33

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

176

0.78

0.33

2.1

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

296

1.17

0.32

2.0

2.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

478

1.14

0.32

1.5

1.3

31.25

27.21

iu/ml

0.10

149

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

363

1.15

0.32

3.9

3.1

1175.04

509.26

ng/l

0.62

290

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

225

2200

1.14

0.30

4.8

4.3

4.64

4.76

mmol/l

1.24

212

2131

(3004716) Salmonella sp identified in Stool by Organism specific culture

162

0.79

0.29

1.2

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

151

0.79

0.29

2.6

2.0

0.08

0.13

e6/l

0.22

142

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

363

0.87

0.28

1.8

2.4

0.64

0.63

ug/l

0.02

160

(36660697) Celiac disease serology panel - Serum

243

1.17

0.28

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

122

1161

1.09

0.28

3.9

2.8

93.71

92.81

ug/l

0.02

115

1121

(3050129) First trimester maternal screen panel - Serum or Plasma

139

0.78

0.27

2.1

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

474

1.12

0.27

1.7

1.5

19.79

20.84

nmol/l

0.22

430

(3023323) Follitropin [Units/volume] in Serum or Plasma

197

1.18

0.27

1.6

1.4

34.26

24.56

iu/l

0.45

164

(42529406) Shigella sp [Presence] in Stool by Culture

0.70

0.26

1.0

1.1

—

(3008898) HLA-B27 [Presence]

132

1.23

0.26

1.1

—

(1002224) Polysomnography panel

180

0.82

0.25

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

161

1.19

0.25

1.6

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.28

0.24

3.3

4.5

131.00

139.20

g/l

0.55

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.72

0.24

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

248

1.14

0.22

1.8

2.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

36.43

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.21

0.0

1.1

—

0.49

—

(3028300) Cannabinoids [Presence] in Urine

208

0.86

0.21

3.0

2.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.21

0.0

1.2

—

306.36

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.00

0.20

0.0

12.0

—

56.00

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.23

0.20

2.2

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

493

1.09

0.20

2.5

2.2

—

(3027008) Opiates [Presence] in Urine

207

0.86

0.20

2.4

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

206

0.86

0.19

2.4

2.1

—

(3027944) Amphetamines [Presence] in Urine

206

0.86

0.19

2.4

2.0

—

(3019977) pH of Arterial blood

157

1.16

0.18

11.2

6.9

7.41

7.43

—

(40768797) Stomach Pathology biopsy report

263

1.12

0.17

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

224

2207

1.09

0.17

5.1

4.7

2.77

2.87

mmol/l

0.97

210

2128

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.73

0.17

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.71

0.17

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.18

0.17

1.5

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1.20

0.16

1.0

1.1

1.14

5.18

u/ml

—

(3000492) Spirometry study

275

0.90

0.15

1.9

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

112

1.17

0.14

1.0

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

532

1.07

0.13

2.6

2.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

134

1.13

0.11

2.4

1.7

297.27

333.41

mu/l

0.19

123

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

204

2065

0.95

0.10

4.2

4.0

5.84

5.73

mmol/l

0.49

191

1954

(3019150) Specific gravity of Urine by Refractometry

537

1.05

0.10

5.1

2.8

1.02

kg/l

0.34

347

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

106

1.14

0.10

1.1

1.2

0.40

3.20

u/ml

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

0.80

0.08

3.0

2.8

23.00

24.66

mmol/l

—

(3028707) Methadone [Presence] in Urine by Screen method

1.14

0.08

2.3

2.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.10

0.08

1.0

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.08

0.08

5.4

2.4

53.71

54.91

—

(4034850) Laboratory test

1.05

0.08

5.1

7.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.13

0.08

1.0

1.1

—

4.93

—

(4024509) Urine culture

0.81

0.07

1.7

1.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.81

0.07

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.81

0.07

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

153

0.91

0.07

1.0

1.1

1.48

1.53

g/l

0.28

153

(3013139) Helicobacter pylori Ag [Presence] in Stool

163

0.92

0.07

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.05

0.07

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

138

1.09

0.06

2.9

3.0

—

(3016879) Cocaine [Presence] in Urine

192

0.93

0.05

2.4

2.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.12

0.05

1.8

1.6

—

(3010813) Leukocytes [#/volume] in Blood

256

2549

1.09

0.05

25.5

16.3

7.52

6.60

e9/l

0.68

249

2507

(3026361) Erythrocytes [#/volume] in Blood

256

2549

1.09

0.05

25.5

16.2

4.60

4.65

e12/l

0.81

249

2510

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

130

0.92

0.04

2.7

1.8

—

(40758558) Short blood count panel - Blood

656

1.03

0.04

8.6

5.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

218

2193

0.97

0.04

4.8

4.3

1.40

1.44

mmol/l

0.82

206

2117

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

200

2013

0.97

0.04

5.6

4.7

38.31

37.58

mmol/mol

0.50

189

1946

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

409

1.03

0.03

1.5

1.8

1.36

1.35

0.06

386

(3014007) Fractional oxyhemoglobin in Arterial blood

1.09

0.03

18.9

9.2

91.62

93.78

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

102

1.08

0.03

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

148

0.94

0.02

2.4

1.7

0.28

0.36

mg/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

148

0.94

0.02

1.0

1.1

—

0.59

—

(3000494) Fungus identified in Specimen by Culture

262

1.03

0.02

1.2

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

163

1.05

0.01

1.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.07

0.01

18.4

9.0

1.67

1.43

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

324

1.02

0.00

2.0

3.0

772.50

233.93

ng/l

0.48

198

(1001926) Buprenorphine [Presence] in Urine by Screen method

159

1.01

0.00

2.4

2.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

208

2079

1.00

0.00

4.1

3.7

1.41

1.31

mmol/l

0.94

195

1988

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.04

0.00

1.2

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

154

0.97

0.00

1.1

0.79

0.86

g/l

0.75

154

(3022621) pH of Urine by Test strip

166

1.03

0.00

4.9

1.8

6.00

6.21

0.49

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

566

1.01

0.00

2.7

3.3

1.11

1.37

ug/l

0.39

532

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.1

—

(4133840) Spirometry

0.00

0.0

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.1

—

(3019060) Gas panel - Arterial blood

0.97

-0.00

1.9

2.7

—

(3022689) Creatine [Moles/volume] in Urine

0.00

-0.00

0.0

1.3

—

10.46

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

-0.00

0.0

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

81.71

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

-0.00

0.0

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.7

—

10.77

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

-0.00

0.0

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.1

—

18.40

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

0.01

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.99

-0.00

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.96

-0.00

1.4

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.7

—

4.63

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

188.24

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.9

—

45.38

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.97

-0.00

2.8

1.9

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.01

-0.00

20.3

9.4

0.69

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.98

-0.00

1.0

1.1

—

1.41

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

583.71

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

0.90

-0.00

1.0

1.1

—

9.10

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.94

-0.00

1.2

1.3

—

86.00

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

15.6

—

1.22

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

-0.00

0.0

1.0

—

6.17

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

0.00

-0.00

0.0

3.4

—

3.40

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.00

-0.00

0.0

3.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

0.00

-0.00

0.0

7.2

—

25.78

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

-0.00

0.0

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

-0.00

0.0

9.8

—

1.25

—

(3014271) Vancomycin [Susceptibility]

0.00

-0.00

0.0

2.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

4.00

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_SCARLET_FEVER and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_SCARLET_FEVER.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: AB1_SCARLET_FEVER – Scarlet fever

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Scarlet fever

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints